{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T13:17:11Z","timestamp":1777814231044,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-094436-BI00"],"award-info":[{"award-number":["RTI2018-094436-BI00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["FPU16\/05896"],"award-info":[{"award-number":["FPU16\/05896"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2018\/141"],"award-info":[{"award-number":["PROMETEO\/2018\/141"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEOII\/2014\/035"],"award-info":[{"award-number":["PROMETEOII\/2014\/035"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["PI14\/00312"],"award-info":[{"award-number":["PI14\/00312"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["CIBER CB06\/04\/0071"],"award-info":[{"award-number":["CIBER CB06\/04\/0071"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.antiviral.2020.104784","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T11:07:59Z","timestamp":1586171279000},"page":"104784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors"],"prefix":"10.1016","volume":"178","author":[{"given":"Aleksandra","family":"Gruevska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela B.","family":"Moragrega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan V.","family":"Esplugues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Blas-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezda","family":"Apostolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.antiviral.2020.104784_bib2","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Antiretroviral Therapy Cohort Collaboration","year":"2017","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104784_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2020.104784_bib4","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142019","volume":"42","author":"Association","year":"2019","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104784_bib5","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/QAI.0000000000001191","article-title":"MicroRNA-210, MicroRNA-331, and MicroRNA-7 are differentially regulated in treated HIV-1-Infected individuals and are associated with markers of systemic inflammation","volume":"74","author":"Ballegaard","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 97","key":"10.1016\/j.antiviral.2020.104784_bib6","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood","volume":"21","author":"Boyum","year":"1968","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104784_bib7","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc Ther"},{"issue":"5","key":"10.1016\/j.antiviral.2020.104784_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chron. Dis."},{"key":"10.1016\/j.antiviral.2020.104784_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.arr.2016.12.004","article-title":"HIV-associated cellular senescence: a contributor to accelerated aging","volume":"36","author":"Cohen","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104784_bib10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/carcin\/bgu134","article-title":"Caught in the cross fire: p53 in inflammation","volume":"35","author":"Cooks","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.antiviral.2020.104784_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mad.2017.07.001","article-title":"Stress, cell senescence and organismal ageing","volume":"170","author":"de Magalh\u00e3es","year":"2018","journal-title":"Mech. Ageing Dev."},{"issue":"9903","key":"10.1016\/j.antiviral.2020.104784_bib12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"issue":"30","key":"10.1016\/j.antiviral.2020.104784_bib13","doi-asserted-by":"crossref","first-page":"12052","DOI":"10.1073\/pnas.1120437109","article-title":"Plasminogen activator inhibitor 1 - insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence","volume":"109","author":"Elzi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104784_bib14","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.1073\/pnas.0708043104","article-title":"Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations","volume":"104","author":"Feng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104784_bib15","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/JVI.76.6.2692-2702.2002","article-title":"Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis","volume":"76","author":"Greenway","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104784_bib16","first-page":"25709","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical Practice Guidelines","volume":"10","author":"Grundy","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"S1","key":"10.1016\/j.antiviral.2020.104784_bib17","article-title":"HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH office of AIDS research by the HIV and aging working group","volume":"60","author":"High","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2020.104784_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jprot.2012.07.021","article-title":"Leukocyte p53 protein biosignature through standard-aligned two-dimensional immunoblotting","volume":"76","author":"Hjelle","year":"2012","journal-title":"J Proteomics"},{"issue":"48","key":"10.1016\/j.antiviral.2020.104784_bib19","doi-asserted-by":"crossref","first-page":"20798","DOI":"10.1073\/pnas.1008076107","article-title":"HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication","volume":"107","author":"Izumi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104784_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bcp.2008.08.030","article-title":"Wild-type p53 in cancer cells: when a guardian turns into a blackguard","volume":"77","author":"Kim","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104784_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb1448","article-title":"Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence","volume":"8","author":"Kortlever","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.antiviral.2020.104784_bib22","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1073\/pnas.92.12.5461","article-title":"Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1","volume":"92","author":"Li","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104784_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/bmm.11.15","article-title":"Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection","volume":"5","author":"Lichtfuss","year":"2011","journal-title":"Biomarkers Med."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104784_bib24","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.4049\/jimmunol.0803526","article-title":"p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury","volume":"182","author":"Liu","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104784_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3892\/ol.2011.300","article-title":"The emerging role of CXCL10 in cancer","volume":"2","author":"Liu","year":"2011","journal-title":"Oncology Letters"},{"issue":"2","key":"10.1016\/j.antiviral.2020.104784_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-146-2-200701160-00003","article-title":"Survival of persons with and without HIV infection in Denmark, 1995\u20132005","volume":"146","author":"Lohse","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.antiviral.2020.104784_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri.2016.99","article-title":"Emerging roles of p53 and other tumour-suppressor genes in immune regulation","volume":"16","author":"Mu\u00f1oz-Fontela","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104784_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bjc.2016.384","article-title":"The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy","volume":"116","author":"Napoli","year":"2017","journal-title":"Br. J. Canc."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104784_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection: ageing, inflammation and HIV infection","volume":"187","author":"Nasi","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104784_bib30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40273-015-0295-6","article-title":"Can the EQ-5D detect meaningful change? A systematic review","volume":"33","author":"Payakachat","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.antiviral.2020.104784_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2796.2007.01906.x","article-title":"Separating cause from effect: how does insulin\/IGF signalling control lifespan in worms, flies and mice?","volume":"263","author":"Piper","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.antiviral.2020.104784_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejphar.2015.08.054","article-title":"Differential effects of anti-TNF-\u03b1 and anti-IL-12\/23 agents on human leukocyte\u2013endothelial cell interactions","volume":"765","author":"R\u00edos-Navarro","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104784_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/hiv.12081","article-title":"The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery","volume":"15","author":"Serrano-Villar","year":"2014","journal-title":"HIV Med."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104784_bib33","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104784_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2105-7-198","article-title":"Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables","volume":"7","author":"Van Belle","year":"2006","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104784_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.174.3.729","article-title":"Fibrinolytic response to tumor necrosis factor in healthy subjects","volume":"174","author":"van der Poll","year":"1991","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104784_bib36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000298","article-title":"Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population","volume":"11","author":"Wandeler","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104784_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1743-422X-4-130","article-title":"Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses","volume":"4","author":"Watson","year":"2007","journal-title":"Virol. J."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104784_bib38","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1128\/JVI.03087-14","article-title":"p53-Derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation","volume":"89","author":"Yoon","year":"2015","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219307430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219307430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:12:02Z","timestamp":1777497122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219307430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"alternative-id":["S0166354219307430"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104784","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104784"}}